Petmed Express Inc Stock Price, News & Analysis

PetMed Express (NASDAQ: PETS), the parent company of PetCareRx, has scheduled its fourth quarter and full fiscal year 2025 earnings conference call for Tuesday, June 10, 2025, at 4:30 PM Eastern Time. The company will release its financial results for the period ended March 31, 2025, before the call.

The management team will host the call followed by a Q&A session. Investors can join via U.S. dial-in (877-407-0789) or international number (201-689-8562). A replay will be available until June 24, 2025, accessible through toll-free (844-512-2921) or international (412-317-6671) numbers using passcode 13753433.

PetMed Express (NASDAQ: PETS) has announced a strategic partnership with Dutch, a virtual veterinary care provider, to expand accessible telehealth services for pets. Through this collaboration, pet parents can access Dutch's virtual veterinary team for 24/7 appointments in 34 states via a monthly membership program. Dutch's platform has completed nearly 700,000 visits and offers treatment for over 150 conditions.

The partnership aims to address the nationwide veterinarian shortage affecting 129 million Americans (38% of the population) who live in vet-care "deserts." Dutch's virtual care platform will integrate with PetMeds' medication services, enabling pet parents to obtain prescriptions efficiently while ensuring professional veterinary guidance remains central to pet healthcare.

PetMed Express (NASDAQ: PETS) is set to ring the Nasdaq Opening Bell on April 11, 2025, in celebration of National Pet Day. The ceremony will feature adoptable rescue dogs from Bidawee, one of the nation's oldest no-kill animal welfare organizations.

Sandra Campos, President & CEO of PetMeds and PetCareRx®, who personally owns three rescue dogs, nine rescue horses, and a senior cat, emphasized the company's commitment to accessible, preventative pet healthcare. The event highlights PetMeds' support for rescue efforts nationwide through their integrated platform, which provides:

• Prescription medications
• Vet-recommended food and supplies
• Trusted guidance and science-backed solutions

Pet lovers are encouraged to participate by sharing their rescue stories on social media using #PawsontheBell and tagging @PetMeds.

PetMed Express (NASDAQ: PETS) has appointed Peter Batushansky to its Board of Directors, effective April 09, 2025. Batushansky, currently a Partner at L2 Capital Partners, brings over 20 years of experience in retail, pet, healthcare, and private equity sectors, including executive roles at WebEyeCare and Allivet.

The appointment marks the third independent director addition since 2024, bringing the board to seven members, with six being independent. Dr. Gian Fulgoni, longtime board member and former Chairman, will retire at the 2025 annual shareholders' meeting.

This appointment follows recent leadership changes, including Leslie C. G. Campbell as Board Chairman in Q4 2024, Sandra Campos as CEO and President in Q1 2025, and new executives in CFO, CAO, COO, and Chief Digital roles. Justin Mennen and Leah Solivan joined the Board in Q2 2025.

PetMed Express (NASDAQ: PETS) has reported its Q3 fiscal 2025 financial results, highlighting several key improvements in its business performance. The company achieved net sales of $53.0 million and improved its gross margin rate to 28.1%, representing an 80 basis points increase compared to the previous year.

The company's Adjusted EBITDA reached $2.0 million, showing a significant improvement from $0.9 million in the prior year period. Management successfully reduced G&A expenses by $2.6 million compared to last year, demonstrating progress in their transformation initiatives focused on operational excellence and financial discipline.

PetMed Express (NASDAQ: PETS) has scheduled its fiscal third quarter 2025 earnings conference call for Monday, February 10, 2025, at 4:30 PM Eastern Time. The company will release its financial results for the quarter ended December 31, 2024, prior to the call.

The earnings call will include a management presentation followed by a Q&A session. Investors can access the call through U.S. dial-in (877-407-0789) or international number (201-689-8562). A replay will be available until February 24, 2025, accessible via toll-free (844-512-2921) or international (412-317-6671) numbers with passcode 13750886.

PetMed Express, Inc., doing business as PetMeds and the parent company of PetCareRx, announced its participation in the 27th Annual ICR Conference, scheduled for January 13-15, 2025 in Orlando, FL.

Sandra Campos, Chief Executive Officer and President, and Robyn D’Elia, Chief Financial Officer, will represent the company and meet with investors. They are scheduled to present at approximately 11:00 a.m. Eastern Time on Monday, January 13, 2025.

A live webcast of the presentation will be available on the “Events & Presentations” section of PetMed’s investor relations website at https://investors.petmeds.com.

PetMeds (NASDAQ: PETS) has announced the adoption of a duration shareholder rights plan to protect shareholders' interests. The plan, effective immediately until December 2, 2025, was implemented in response to recent significant stock accumulations and concerns that shares don't reflect the company's inherent value. Under the plan, shareholders will receive one right per common stock share as of December 16, 2024. These rights become exercisable if an entity acquires 12.5% or more of outstanding shares without Board approval, allowing other shareholders to purchase additional shares at a 50% discount to market price.

PetMed Express (NASDAQ: PETS) has partnered with Ordergroove to enhance its subscription and membership capabilities. The collaboration aims to modernize PETS' Autoship program by implementing advanced platform features including prepaid subscriptions, self-service management, and personalized promotions. The partnership integrates product catalogs from both PetMeds and PetCareRx, creating a unified subscription membership experience. CEO Sandra Campos emphasized that this strategic move will support innovation while increasing customer satisfaction and retention. The implementation is expected to expand PETS' subscriber base and improve service accessibility while enabling faster market innovations.